Literature DB >> 18978570

Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center.

Max Dahele1, Shannon Pearson, Tom Purdie, Jean-Pierre Bissonnette, Kevin Franks, Anthony Brade, John Cho, Alex Sun, Andrew Hope, Andrea Marshall, Jane Higgins, Andrea Bezjak.   

Abstract

INTRODUCTION: With the anticipation of improved outcomes, especially for patients with early-stage non-small cell lung cancer, stereotactic body radiation therapy (SBRT) has been rapidly introduced into the thoracic radiation oncology community. Although at first glance lung SBRT might seem methodologically similar to conventional radiotherapy, there are important differences in its execution that require particular consideration. The objective of this paper is to highlight these and other issues to contribute to the safe and effective diffusion of lung SBRT. We discuss practical challenges that have been encountered in the implementation of lung SBRT at a single, large institution and emphasize the importance of a systematic approach to the design of lung SBRT services.
METHODS: Specific technical and clinical components that were identified as being important during the development of lung SBRT at Princess Margaret Hospital are described. The clinical system that evolved from these is outlined.
RESULTS: Using this clinical framework the practical topics addressed include: patient assessment, simulation and treatment planning, tumor and organ at risk delineation, trial set up before treatment, on-line image-guidance, and patient follow-up.
CONCLUSIONS: The potential gain in therapeutic ratio that is theoretically possible with lung SBRT can only be realized if the tumor is adequately irradiated and normal tissue spared. A discussion of the component parts of lung SBRT is presented. It is a complex process and specific challenges need to be overcome to effect the satisfactory transition of lung SBRT into routine practice.

Entities:  

Mesh:

Year:  2008        PMID: 18978570     DOI: 10.1097/JTO.0b013e31818b1771

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  13 in total

Review 1.  Recent advances in radiotherapy for thoracic tumours.

Authors:  Michael Fay; Christopher M Poole; Gary Pratt
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 2.  Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer.

Authors:  Max Dahele; Anthony Brade; Shannon Pearson; Andrea Bezjak
Journal:  CMAJ       Date:  2009-06-23       Impact factor: 8.262

Review 3.  Alternatives to surgery in early stage disease-stereotactic body radiotherapy.

Authors:  Meredith Elana Giuliani; Andrea Bezjak
Journal:  Transl Lung Cancer Res       Date:  2013-10

4.  Cleaning the dose falloff in lung SBRT plan.

Authors:  Dharmin Desai; Ganesh Narayanasamy; Milan Bimali; Ivan Cordrey; Hisham Elasmar; Senthamizhchelvan Srinivasan; Ellis Lee Johnson
Journal:  J Appl Clin Med Phys       Date:  2020-12-07       Impact factor: 2.102

Review 5.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

6.  Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer.

Authors:  T Yung; M E Giuliani; L W Le; A Sun; B C J Cho; A Bezjak; A Brade; A J Hope
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

7.  Development and Evaluation of Patient Education Materials for Elderly Lung Cancer Patients.

Authors:  Natalie Jewitt; Andrew J Hope; Robin Milne; Lisa W Le; Janet Papadakos; Nazek Abdelmutti; Pamela Catton; Meredith E Giuliani
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

8.  A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).

Authors:  Gregory M M Videtic; Chen Hu; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Steven E Schild; Ritsuko Komaki; James J Urbanic; Robert D Timmerman; Hak Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-17       Impact factor: 7.038

9.  Usefulness of target delineation based on the two extreme phases of a four-dimensional computed tomography scan in stereotactic body radiation therapy for lung cancer.

Authors:  Seong Soon Jang; Gil Ja Huh; Suk Young Park; Po Song Yang; EunYoun Cho
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500

Review 10.  Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases.

Authors:  Enrique Gutiérrez; Irving Sánchez; Omar Díaz; Adrián Valles; Ricardo Balderrama; Jesús Fuentes; Brenda Lara; Cipatli Olimón; Víctor Ruiz; José Rodríguez; Luis H Bayardo; Matthew Chan; Conrad J Villafuerte; Jerusha Padayachee; Alexander Sun
Journal:  Curr Oncol       Date:  2021-07-15       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.